Abstract
The aims of this review were to describe the case of a patient with debilitating neuroarthropathy of the ankles and feet and reveal a primary systemic (amyloid light chain, AL) amyloidosis and to review the relevant literature concerning the peripheral neuropathy and neuroarthropathy due to amyloidosis. We will emphasize the diagnostic pitfalls and discuss prognosis and treatments of both the peripheral neuropathy and the arthropathy related to AL amyloidosis. This is a descriptive case report of a patient with neuroarthropathy of the lower limbs due to AL amyloidosis. A review and discussion of relevant literature were conducted, based on a PubMed search from 1973 to December 2013. A 51-year-old female was diagnosed with AL amyloidosis after 20 months of investigation of small painful deformities of the feet. Chronic peripheral neuropathy occurs as a manifestation of AL amyloidosis in 25 % of cases. It may exceptionally be complicated by neuroarthropathy. In this case, the paucity of clinical and electrophysiological signs of the neuropathy delayed the diagnosis, leading to a severe arthropathy. The massive destruction of the joints dominated the clinical and the poor functional outcome. Diagnosis of AL amyloidosis should be considered in the presence of a mild peripheral neuropathy and a distal destructive and painless arthropathy. The two key diagnostic procedures are serum protein electrophoresis and nerve biopsy. Delay in treatment worsens the prognosis.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Gertz MA (2011) Immunoglobulin light chain amyloidosis: 2011 update on diagnosis, risk-stratification, and management. Am J Hematol 86(2):180–186. doi:10.1002/ajh.21934
Gertz MA, Kyle RA (1989) Primary systemic amyloidosis—a diagnostic primer. Mayo Clin Proc Mayo Clin 64(12):1505–1519
M'Bappe P, Grateau G (2012) Osteo-articular manifestations of amyloidosis. Best Pract Res Clin Rheumatol 26(4):459–475. doi:10.1016/j.berh.2012.07.003
Simmons Z, Specht CS (2010) The neuromuscular manifestations of amyloidosis. J Clin Neuromuscul Dis 11(3):145–157. doi:10.1097/CND.0b013e3181d05994
Rajkumar SV, Gertz MA, Kyle RA (1998) Prognosis of patients with primary systemic amyloidosis who present with dominant neuropathy. Am J Med 104(3):232–237
Duston MA, Skinner M, Anderson J, Cohen AS (1989) Peripheral neuropathy as an early marker of AL amyloidosis. Arch Intern Med 149(2):358–360
Kyle RA, Greipp PR (1983) Amyloidosis (AL). Clinical and laboratory features in 229 cases. Mayo Clin Proc Mayo Clin 58(10):665–683
Gertz MA (2013) Immunoglobulin light chain amyloidosis: 2013 update on diagnosis, prognosis, and treatment. Am J Hematol 88(5):416–425. doi:10.1002/ajh.23400
Kelly JJ Jr, Kyle RA, O’Brien PC, Dyck PJ (1979) The natural history of peripheral neuropathy in primary systemic amyloidosis. Ann Neurol 6(1):1–7. doi:10.1002/ana.410060102
Gertz MA, Lacy MQ, Dispenzieri A (1999) Amyloidosis: recognition, confirmation, prognosis, and therapy. Mayo Clin Proc Mayo Clin 74(5):490–494. doi:10.4065/74.5.490
Gherardi R, Zuber M, Viard JP (1988) Dysglobulinemic neuropathies. Rev Neurol 144(6–7):391–408
Scott RB, Elmore SM, Brackett NC Jr, Harris WO Jr, Still WJ (1973) Neuropathic joint disease (Charcot joints) in Waldenstrom’s macroglobulinemia with amyloidosis. Am J Med 54(4):535–538
Peitzman SJ, Miller JL, Ortega L, Schumacher HR, Fernandez PC (1976) Charcot arthropathy secondary to amyloid neuropathy. JAMA: J Am Med Assoc 235(13):1345–1347
Pruzanski W, Baron M, Shupak R (1981) Neuroarthropathy (Charcot joints) in familial amyloid polyneuropathy. J Rheumatol 8(3):477–481
Shiraishi M, Ando Y, Mizuta H, Nakamura E, Takagi K, Ando M (1997) Charcot knee arthropathy with articular amyloid deposition in familial amyloidotic polyneuropathy. Scand J Rheumatol 26(1):61–64
Duarte C, Serrano PR, Mariano JC (2009) Charcot arthropathy in a patient with hereditary paramyloidosis. Acta Reumatol Port 34(2B):436–437
Wilmes D, Wautier D, Jonckheere S, Cornu O, Yombi JC (2012) Neuroarthropathy secondary to transthyretin amyloidosis (ATTR V30M). Acta Clin Belg 67(5):372–374. doi:10.1179/ACB.67.5.2062694
Lakhanpal S, Li CY, Gertz MA, Kyle RA, Hunder GG (1987) Synovial fluid analysis for diagnosis of amyloid arthropathy. Arthritis Rheum 30(4):419–423
Lithner F (1976) Skin lesions of the legs and feet and skeletal lesions of the feet in familial amyloidosis with polyneuropathy. Acta Med Scand 199(3):197–202
Richard JL, Almasri M, Schuldiner S (2012) Treatment of acute Charcot foot with bisphosphonates: a systematic review of the literature. Diabetologia 55(5):1258–1264. doi:10.1007/s00125-012-2507-3
Wukich DK, Sung W (2009) Charcot arthropathy of the foot and ankle: modern concepts and management review. J Diabetes Complicat 23(6):409–426. doi:10.1016/j.jdiacomp.2008.09.004
Molines L, Darmon P, Raccah D (2010) Charcot’s foot: newest findings on its pathophysiology, diagnosis and treatment. Diabetes Metab 36(4):251–255. doi:10.1016/j.diabet.2010.04.002
Rogers LC, Frykberg RG, Armstrong DG, Boulton AJ, Edmonds M, Van GH, Hartemann A, Game F, Jeffcoate W, Jirkovska A, Jude E, Morbach S, Morrison WB, Pinzur M, Pitocco D, Sanders L (2011) The Charcot foot in diabetes. Diabetes Care 34(9):123-9. doi10.2337/dc11-0844
Acknowledgments
The authors thank Alexander Kai-Lik So, PhD, FRCP, for his review of the manuscript and helpful comments.
Disclosures
None.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Andrei, I.A., Kuntzer, T., Lobrinus, J.A. et al. Neuroarthropathy of the foot revealing primary systemic amyloidosis: case report and literature review. Clin Rheumatol 35, 535–539 (2016). https://doi.org/10.1007/s10067-014-2782-0
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10067-014-2782-0